ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000225506.2	ABT-263 (navitoclax)	Liver hepatocellular carcinoma	0.024414551	Resistant
ENSG00000225506.2	ABT-263 (navitoclax)	Breast invasive carcinoma	0.014868515	Sensitive